Trastuzumab deruxtecan (T-DXd) in HER2-low metastatic breast cancer treatment. Tarantino P, Tolaney SM, Curigliano G. Ann Oncol 2023 Jul 25:S0923-7534(23)00767-6. doi: 10.1016/j.annonc.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tarantino P, Tolaney SM, Curigliano G. Trastuzumab deruxtecan (T-DXd) in HER2-low metastatic breast cancer treatment. Ann Oncol 2023 Jul 25:S0923-7534(23)00767-6. doi: 10.1016/j.annonc.2023.
PMID: 37499870